Movement Alert｜Hims & Hers Health Falls 5.05% in Regular Trading, Proposed Securities Sale Filing Triggers Profit-Taking After Sharp Rally

Market Focus06-23 00:36

On June 23, Hims & Hers Health declined 5.05% in regular trading, trading at $33.7/share, with turnover of $451 million.

On the news front, the company recently filed a proposed sale of securities announcement (Form 144), signaling potential share dilution. The filing came after the stock had rallied sharply from approximately $28.91 to around $34 over the preceding week — a cumulative gain of over 17% — prompting profit-taking among investors. Additionally, ownership change statements were filed on June 18, further amplifying concerns over insider selling pressure.

The selloff stands in contrast to a string of recent positive catalysts, including Barclays raising its price target to $39 from $29 while maintaining an Overweight rating, Goldman Sachs upgrading GLP-1 weight-loss drug market expectations, and the company reporting three out of four recent weeks with year-over-year sales growth. Despite these fundamental improvements, the securities sale filing provided a near-term overhang sufficient to trigger a reversal of the prior rally.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1193490379?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 00:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1193490379","market":"us","top_or_hot":-1,"title":"Movement Alert｜Hims & Hers Health Falls 5.05% in Regular Trading, Proposed Securities Sale Filing Triggers Profit-Taking After Sharp Rally","media":"Market Focus","content":"<p><p>On June 23, Hims & Hers Health declined 5.05% in regular trading, trading at $33.7/share, with turnover of $451 million.</p><p>On the news front, the company recently filed a proposed sale of securities announcement (Form 144), signaling potential share dilution. The filing came after the stock had rallied sharply from approximately $28.91 to around $34 over the preceding week — a cumulative gain of over 17% — prompting profit-taking among investors. Additionally, ownership change statements were filed on June 18, further amplifying concerns over insider selling pressure.</p><p>The selloff stands in contrast to a string of recent positive catalysts, including Barclays raising its price target to $39 from $29 while maintaining an Overweight rating, Goldman Sachs upgrading GLP-1 weight-loss drug market expectations, and the company reporting three out of four recent weeks with year-over-year sales growth. Despite these fundamental improvements, the securities sale filing provided a near-term overhang sufficient to trigger a reversal of the prior rally.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hims & Hers Health Falls 5.05% in Regular Trading, Proposed Securities Sale Filing Triggers Profit-Taking After Sharp Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hims & Hers Health Falls 5.05% in Regular Trading, Proposed Securities Sale Filing Triggers Profit-Taking After Sharp Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-23 00:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 23, Hims & Hers Health declined 5.05% in regular trading, trading at $33.7/share, with turnover of $451 million.</p><p>On the news front, the company recently filed a proposed sale of securities announcement (Form 144), signaling potential share dilution. The filing came after the stock had rallied sharply from approximately $28.91 to around $34 over the preceding week — a cumulative gain of over 17% — prompting profit-taking among investors. Additionally, ownership change statements were filed on June 18, further amplifying concerns over insider selling pressure.</p><p>The selloff stands in contrast to a string of recent positive catalysts, including Barclays raising its price target to $39 from $29 while maintaining an Overweight rating, Goldman Sachs upgrading GLP-1 weight-loss drug market expectations, and the company reporting three out of four recent weeks with year-over-year sales growth. Despite these fundamental improvements, the securities sale filing provided a near-term overhang sufficient to trigger a reversal of the prior rally.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1193490379","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1193490379","pubTimestamp":1782146210,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 23, Hims & Hers Health declined 5.05% in regular trading, trading at $33.7/share, with turnover of $451 million.On the news front, the company recently filed a proposed sale of securities...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"动向提示|Hims&Hers Health常规交易跌5.05%拟提交证券出售备案引发大幅反弹后获利了结","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"On June 23, Hims & Hers Health declined 5.05% in regular trading, trading at $33.7/share, with turnover of $451 million.On the news front, the company recently filed a proposed sale of securities announcement (Form 144), signaling potential share dilution. The filing came after the stock had rallied sharply from approximately $28.91 to around $34 over the preceding week — a cumulative gain of over 17% — prompting profit-taking among investors. Additionally, ownership change statements were filed on June 18, further amplifying concerns over insider selling pressure.The selloff stands in contrast to a string of recent positive catalysts, including Barclays raising its price target to $39 from $29 while maintaining an Overweight rating, Goldman Sachs upgrading GLP-1 weight-loss drug market expectations, and the company reporting three out of four recent weeks with year-over-year sales growth. Despite these fundamental improvements, the securities sale filing provided a near-term overhang sufficient to trigger a reversal of the prior rally.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1193490379","isCrawlerRequest":true}